. . . . "8892"^^ . . . . . . . . . . . . "11446358"^^ . . . . . "1975-10-30"^^ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . "1122617103"^^ . . . . . . . . . . . . . . . "Khademhosseini in 2008"@en . ""@en . . . . . . "1975-10-30"^^ . . . "Ali Khademhosseini"@en . "Ali Khademhosseini (Persian: \u0639\u0644\u06CC \u062E\u0627\u062F\u0645\u200C\u062D\u0633\u06CC\u0646\u06CC, born October 30, 1975, Tehran, Iran) is the Director and CEO of the Terasaki Institute and former professor at the University of California-Los Angeles where he held a multi-departmental professorship in Bioengineering, Radiology, Chemical, and Biomolecular Engineering and the Director of Center for Minimally Invasive Therapeutics (C-MIT). From 2005 to 2017, he was a professor at Harvard Medical School, and the Wyss Institute for Biologically Inspired Engineering. His studies have been cited ~100,000 times (H index = 160). Khademhosseini is best known for developing hydrogels for tissue engineering and bioprinting. Khademhosseini is a recipient of The Massachusetts Institute of Technology Outstanding Undergraduate mentor award and a recipient of the Presidential Career Award for Scientists and Engineers by President Barack Obama. Every year since 2014 he has been selected by Thomson Reuters as one of the World's Most Influential Minds. By the number of citations, he is the most cited author of in various journals in the field of biomaterials like Biomaterials, , Biofabrication, ."@en . . "In vitro study of bone marrow derived progenitor cells in liver-like microenvironments"@en . . . . . . . . . ""@en . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . "Ali Khademhosseini (Persian: \u0639\u0644\u06CC \u062E\u0627\u062F\u0645\u200C\u062D\u0633\u06CC\u0646\u06CC, born October 30, 1975, Tehran, Iran) is the Director and CEO of the Terasaki Institute and former professor at the University of California-Los Angeles where he held a multi-departmental professorship in Bioengineering, Radiology, Chemical, and Biomolecular Engineering and the Director of Center for Minimally Invasive Therapeutics (C-MIT). From 2005 to 2017, he was a professor at Harvard Medical School, and the Wyss Institute for Biologically Inspired Engineering. His studies have been cited ~100,000 times (H index = 160). Khademhosseini is best known for developing hydrogels for tissue engineering and bioprinting."@en . "Nanoscale and microscale approaches for engineering the in vitro cellular microenvironment"@en . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . "2001"^^ . . . . . "2005"^^ . . . . ""@en . "Ali Khademhosseini"@en . . . "Terasaki Institute"@en . . "Ali Khademhosseini"@en . . . . . . . . . . . . . . .